Analyte Sensor with Antiglycolytic Agent for Immediate Glucose Accuracy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional glucose monitoring techniques for diabetics are invasive, inconvenient, and prone to spurious low readings, especially during the initial hours after sensor placement, which can lead to delayed or inaccurate glucose level reporting and increased risk of hyperglycemic or hypoglycemic episodes.
Innovation Solution
The development of analyte sensors with an antiglycolytic agent or its precursor, which are positioned beneath the skin to minimize spurious low readings by retarding glucose consumption by living cells, allowing for immediate and accurate glucose monitoring with reduced calibration requirements.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional analyte sensors are used, then continuous monitoring is achieved, but spurious low readings occur during the initial hours after positioning
Solution Approach 1:
The sensor is pre-calibrated in the laboratory before implantation, establishing an initial calibration curve that anticipates the sensor's response characteristics. This preliminary calibration action eliminates the need for post-implantation waiting periods and ensures immediate accurate readings by pre-compensating for any initial response delays.
Solution Approach 2:
The system incorporates feedback mechanisms that continuously monitor sensor responses and compare them against expected values. When deviations indicating spurious readings are detected, the system automatically adjusts or flags the measurements, ensuring only accurate analyte concentrations are reported to the user.
2Reliability
If frequent calibration is performed to eliminate spurious readings, then reading accuracy improves, but device complexity and user convenience deteriorate
Solution Approach 1:
The sensor is pre-calibrated in the laboratory before implantation, establishing an initial calibration curve that anticipates the sensor's response characteristics. This preliminary calibration action eliminates the need for post-implantation waiting periods and ensures immediate accurate readings by pre-compensating for any initial response delays.
Solution Approach 2:
The sensor system performs self-calibration using its inherent response characteristics and built-in reference mechanisms. The sensor automatically adjusts for drift and calibration variations without requiring user intervention, thereby maintaining high reading accuracy while reducing operational complexity.
3Productivity
If sensor positioning is performed correctly, then continuous monitoring is enabled, but spurious low readings occur during the first night post-positioning
Solution Approach 1:
The sensor is pre-calibrated in the laboratory before implantation, establishing an initial calibration curve that anticipates the sensor's response characteristics. This preliminary calibration action eliminates the need for post-implantation waiting periods and ensures immediate accurate readings by pre-compensating for any initial response delays.
Solution Approach 2:
The system dynamically adjusts operational parameters such as detection sensitivity and calibration curves based on real-time sensor performance and environmental conditions. This parameter adaptation allows the sensor to maintain high reading accuracy throughout the monitoring period, including during the first night post-positioning, without requiring user intervention.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These sensors provide clinically accurate glucose data immediately after placement with minimal interruptions due to spurious readings, reducing the need for frequent calibrations and enabling continuous, reliable glucose monitoring.
Implementation Method 1
the determination of the blood glucose level using calorimetric, electrochemical, or photometric detection
Implementation Method 2
sensors that include an antiglycolytic agent or precursor thereof... retarding glucose consumption by living cells
Data Source
AI summary
Devices and methods for determining the concentration of an analyte are provided. Embodiments of the subject devices include analyte monitoring systems that include an analyte sensor capable of providing clinically accurate analyte data without a substantial time delay after operably positioning the sensor in a patient. Embodiments of the subject methods include operably positioning an analyte sensor in a patient and obtaining clinically accurate analyte data without a substantial time delay after the positioning. Also provided are systems and kits for use in analyte monitoring.


